Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cat hair immunotherapy for cat allergy
NCT00987909Phase 2Completed
- Sponsor
- ALK-Abelló
- Start
- Sep 2009
- Primary completion
- Mar 2010
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Standardized allergenic extract, cat hair in cat allergy (4 arms), sponsored by ALK-Abelló. Primary endpoint: Adverse Events at 16 weeks. Started Sep 2009; status: completed.
02
Drugs
Standardized allergenic extract, cat hair
03
Conditions
cat allergy
Beyond the preview
Go deeper on NCT00987909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00987909.